Related Experiment Video

Updated: May 7, 2026

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein
08:26

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein

Published on: June 12, 2018

Telomerase regulation: a key to inhibition? (Review)

Diego L Mengual Gómez1, Hernán G Farina, Daniel E Gómez

  • 1Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina.

International Journal of Oncology
|September 18, 2013
PubMed

Insights

Telomerase, a key factor in cancer cells, offers multiple therapeutic targets beyond just expression or activity. Understanding its subunit regulation is essential for novel cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase is frequently found in tumor cells but not normal cells, making it a significant cancer therapy target.
  • Telomerase is a complex enzyme with multiple regulatory mechanisms, including expression, phosphorylation, assembly, and localization.

Purpose of the Study:

  • To review the current understanding of regulatory mechanisms governing telomerase complex subunits.
  • To explore the potential therapeutic applications of modulating these regulatory mechanisms in cancer treatment.

Main Methods:

  • Comprehensive literature review of studies on telomerase regulation.
  • Analysis of known regulatory pathways affecting telomerase subunit assembly, activity, and localization.
  • Hypothesizing novel therapeutic strategies based on subunit regulation.

Main Results:

  • Telomerase activity can be modulated through various mechanisms beyond direct inhibition of its expression or enzymatic function.
  • Specific regulatory pathways of telomerase subunits offer distinct targets for therapeutic intervention.
  • Understanding subunit regulation provides a broader scope for developing anti-cancer strategies.

Conclusions:

  • Targeting telomerase subunit regulation presents a promising avenue for cancer therapy, offering alternatives to direct telomerase inhibition.
  • Further research into these regulatory mechanisms could lead to the development of novel senolytic and apoptotic cancer treatments.

More Related Videos

In vitro Reconstitution of the Active T. castaneum Telomerase09:25

In vitro Reconstitution of the Active T. castaneum Telomerase

Published on: July 14, 2011

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...